Our Analyzers
Quanterix HD-X
Ultrasensitive Immunoassay Platform
Precision Bead-Based Detection
Uses bead-based Simoa® technology to detect and quantify biomarkers at ultra-low levels with exceptional precision
Versatile and Expandable Menu
Supports 80+ validated neurology, cardiology and oncology assays with custom development options
Quanterix SP-X
Planar Array Benchtop Platform
Customizable Multiplex Panels
Design flexible assays to measure multiple cytokines and chemokines simultaneously with high sensitivity
Targeted Immune Profiling
Ideal for profiling inflammatory markers in neurology, oncology, and immunology research
Alamar ARGO HT
Semi-Targeted Proteomics Platform
Comprehensive and Translational
Detects 120+ central nervous system and inflammatory markers in a single panel in both human and mouse models
Powered by NULISA™ Technology
Uses DNA-tagged antibodies and signal amplification for precise protein detection, from 25 µL of sample
illumina NextSeq 2000
Next-Generation Sequencing Platform
XLEAP-SBS Chemistry
Advanced sequencing chemistry enables faster runs and supports diverse project sizes
Flexible Flow Cell Options
Choose from multiple flow cell configurations to match throughput needs
In partnership with the UBC Sequencing and Bioinformatics Consortium (SBC)
Fujirebio Lumipulse G1200
Clinical-Grade Immunoassay Platform
Automated CLEIA Technology
Uses chemiluminescent enzyme immunoassay (CLEIA) for precise, high-sensitivity biomarker detection
Health Canada Approved
Supports a wide range of validated tests for clinical and research use
Abbott i-STAT Alinity
Rapid Point-of-Care Testing
Quick Results with One Drop
Uses just a single drop of blood to measure GFAP and UCH-L1, delivering results in 15 minutes
Portable and Efficient
Handheld device ideal for traumatic brain injury screening anywhere
Page Last Updated:
Core Facility for Neurology Biomarker Innovation 